Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Cellosaurus is database indexing available cell lines from various collections: American Type Culture Collection (ATCC), Bioresource Collection and Research Center, Taiwan (BCRC), Banco de Células do Rio de Janeiro (BCRJ), CellBank Australia (CBA), Collection of Cell Lines in Veterinary Medicine (CCLV), Cell Lines Service (CLS), Coriell, Drosophila Genomics Resource Center (DGRC), Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ), European Bank for induced pluripotent Stem Cells (EBiSC), European Collection of Authenticated Cell Cultures (ECACC), Interlab Cell Line Collection (ICLC), Institute for Fermentation Osaka (IFO), Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER) biobank, Japanese Collection of Research Bioresources (JCRB) Cell Bank, Kunming Cell Bank of Type Culture Collection (KCB), Korean Cell Line Bank (KCLB), Millipore, National Cell Bank of Iran (NCBI_Iran), National Cancer Institute - Developmental Therapeutics Program (NCI-DTP), NINDS Human Cell and Data Repository (NHCDR), NIH AIDS Reagent Program (NIH-ARP), NISES, RIKEN Bioresource Center Cell Bank (RCB), Royan Stem Cell Bank (RSCB), Tick Cell Biobank (TCB), Tohoku University cell line catalog (TKG), and Ximbio.
| Name | Proper Citation | Organism | Disease |
Comments |
Defining Citation | Category | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CB6B Resource Report Resource Website |
ECACC Cat# 88052060, RRID:CVCL_E519 | Homo sapiens (Human) | Population: Caucasian., Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel. |
PMID:1363422 PMID:8307784 PMID:8813743 PMID:28360230 PMID:29171935 PMID:30844424 |
Transformed cell line | Female | CBG-IB | ECACC | 88052060 | dbMHC:48533, ECACC:88052060, IHW:IHW09060, IPD-IMGT/HLA:10397, Wikidata:Q54808655 |
CVCL_E519 | 2026-07-25 04:23:13 | 0 | |||
|
BSH017 Resource Report Resource Website |
ECACC Cat# 94082280, RRID:CVCL_E503 | Homo sapiens (Human) | Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel. |
PMID:8307784 PMID:30844424 |
Transformed cell line | Sex unspecified | BSH 017 | ECACC | 94082280 | dbMHC:48518, ECACC:94082280, IHW:IHW09180, IPD-IMGT/HLA:11722, Wikidata:Q54798400 |
CVCL_E503 | 2026-07-25 04:22:11 | 0 | |||
|
BSH012 Resource Report Resource Website |
ECACC Cat# 94082279, RRID:CVCL_E502 | Homo sapiens (Human) | Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel. |
PMID:8307784 PMID:30844424 |
Transformed cell line | Female | BSH 012 | ECACC | 94082279 | dbMHC:48517, ECACC:94082279, IHW:IHW09179, IPD-IMGT/HLA:11721, Wikidata:Q54798399 |
CVCL_E502 | 2026-07-25 04:22:11 | 0 | |||
|
BTB Resource Report Resource Website Possibly Discontinued |
ECACC Cat# 88052067, RRID:CVCL_E505 | Homo sapiens (Human) | Population: Caucasian; Scandinavian., Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel. |
PMID:8813743 PMID:28360230 PMID:29171935 PMID:30844424 |
Transformed cell line | Male | ECACC | 88052067 | dbMHC:48520, ECACC:88052067, IHW:IHW09067, IPD-IMGT/HLA:11625, Wikidata:Q54798505 |
CVCL_E505 | 2026-07-25 04:22:15 | 0 | ||||
|
BUD-8 Resource Report Resource Website |
ECACC Cat# 90031532, RRID:CVCL_2321 | Homo sapiens (Human) | Senescence: Senesces at ~8 PDL (ATCC=CRL-1554)., Characteristics: Highly sensitive to interferon and can be used in assays of interferon activity (ATCC=CRL-1554)., Population: Caucasian. | Finite cell line | Female | ECACC | 90031532 | CLO:CLO_0002051, CLDB:cl507, CLDB:cl508, ATCC:CRL-1554, BioSample:SAMN03471395, ChEMBL-Cells:CHEMBL3307997, ChEMBL-Targets:CHEMBL612591, ECACC:90031532, IZSLER:BS CL 11, PubChem_Cell_line:CVCL_2321, Wikidata:Q54798639 |
CVCL_2321 | 2026-07-25 04:22:17 | 0 | |||||
|
HEL 12469 Resource Report Resource Website |
ECACC Cat# 94101201, RRID:CVCL_2479 | Homo sapiens (Human) | PMID:22239852 | Finite cell line | Sex unspecified | HEL-12469, HEL12469, Human Embryonic Lung 12469 | ECACC | 94101201 | CLO:CLO_0003680, CLDB:cl1593, ECACC:94101201, Wikidata:Q54882502 |
CVCL_2479 | 2026-07-25 04:40:43 | 0 | ||||
|
HEL 299 Resource Report Resource Website 1+ mentions |
ECACC Cat# 87042207, RRID:CVCL_2480 | Homo sapiens (Human) | Population: African American. |
PMID:375235 PMID:6254071 PMID:6988327 PMID:7065527 |
Finite cell line | Male | HEL-299, Hel-299, Hel 299, HEL299 | ECACC | 87042207 | CLO:CLO_0003681, CLDB:cl1586, CLDB:cl1587, CLDB:cl1589, CLDB:cl1590, AddexBio:T0016051/5020, ATCC:CCL-137, BCRC:60117, BioSample:SAMN03471455, CCRID:5301HUM-KCB15024YJ, ChEMBL-Cells:CHEMBL3308663, ChEMBL-Targets:CHEMBL614819, CLS:300193, ECACC:87042207, IPD-IMGT/HLA:10725, IZSLER:BS CL 49, KCB:KCB 2015024YJ, KCLB:10137, PubChem_Cell_line:CVCL_2480, Wikidata:Q54882503 |
CVCL_2480 | 2026-07-25 04:40:43 | 6 | |||
|
HARA [Human B-cell IHW] Resource Report Resource Website |
ECACC Cat# 94082242, RRID:CVCL_E688 | Homo sapiens (Human) | Population: Japanese., Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel. |
PMID:8307784 PMID:30844424 |
Transformed cell line | Sex unspecified | ECACC | 94082242 | dbMHC:48884, ECACC:94082242, IHW:IHW09142, IPD-IMGT/HLA:11685, Wikidata:Q54881312 |
CVCL_E688 | 2026-07-25 04:40:19 | 0 | ||||
|
HAY,BD Resource Report Resource Website |
ECACC Cat# 94082222, RRID:CVCL_E691 | Homo sapiens (Human) | Population: Aboriginal Australian., Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel. | PMID:8307784 | Transformed cell line | Male | HAY, BD, TER301, TER-301, Ter 301, TER357, TER-357, Ter 357, TER493, TER-493, Ter-493, Ter 493 | ECACC | 94082222 | dbMHC:48887, ECACC:94082222, IHW:IHW09123, IPD-IMGT/HLA:11667, Wikidata:Q54881341 |
CVCL_E691 | 2026-07-25 04:40:20 | 0 | |||
|
HAU,ML Resource Report Resource Website |
ECACC Cat# 94082257, RRID:CVCL_E690 | Homo sapiens (Human) | Population: Asian., Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel. |
PMID:8307784 PMID:30844424 |
Transformed cell line | Male | HAU, ML | ECACC | 94082257 | dbMHC:48886, ECACC:94082257, IHW:IHW09157, IPD-IMGT/HLA:11700, Wikidata:Q54881333 |
CVCL_E690 | 2026-07-25 04:40:17 | 0 | |||
|
HAY,KJ Resource Report Resource Website |
ECACC Cat# 94082296, RRID:CVCL_E692 | Homo sapiens (Human) | Population: Aboriginal Australian., Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel. |
PMID:8307784 PMID:30844424 |
Transformed cell line | Male | HAY, KJ | ECACC | 94082296 | dbMHC:48888, ECACC:94082296, IHW:IHW09196, IPD-IMGT/HLA:11737, Wikidata:Q54881342 |
CVCL_E692 | 2026-07-25 04:40:18 | 0 | |||
|
HCA24 Resource Report Resource Website |
ECACC Cat# 06061903, RRID:CVCL_2467 | Homo sapiens (Human) | Colon adenocarcinoma |
PMID:3718830 PMID:25926053 |
Cancer cell line | Male | HCA-24 | ECACC | 06061903 | ECACC:06061903, GEO:GSM1448109, GEO:GSM3145580, GEO:GSM3145707, Wikidata:Q54881489, Ximbio:152462 |
CVCL_2467 | 2026-07-25 04:40:21 | 0 | |||
|
HCA2 [Human colon carcinoma] Resource Report Resource Website |
ECACC Cat# 06061901, RRID:CVCL_2056 | Homo sapiens (Human) | Rectosigmoid adenocarcinoma | PMID:3718830 | Cancer cell line | Female | HCA-2 | ECACC | 06061901 | ECACC:06061901, GEO:GSM3145579, GEO:GSM3145706, Wikidata:Q54881488, Ximbio:152461 |
CVCL_2056 | 2026-07-25 04:40:21 | 0 | |||
|
HeLa DH Resource Report Resource Website 1+ mentions |
ECACC Cat# 96112022, RRID:CVCL_2483 | Homo sapiens (Human) | Human papillomavirus-related endocervical adenocarcinoma | Population: African American. | Cancer cell line | Female | ECACC | 96112022 | CLO:CLO_0003690, ECACC:96112022, Wikidata:Q54882526 |
cvcl_0030 | CVCL_2483 | 2026-07-25 04:40:44 | 3 | |||
|
HeLa Resource Report Resource Website 10000+ mentions Discontinued |
ECACC Cat# 93021013, RRID:CVCL_0030 | Homo sapiens (Human) | Human papillomavirus-related endocervical adenocarcinoma | Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut). |
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987 |
Cancer cell line | Female | HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri | ECACC | 93021013 | BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
CVCL_0030 | 2026-07-25 04:40:44 | 39012 | ||
|
HeLa BU-25 Resource Report Resource Website |
ECACC Cat# 85022104, RRID:CVCL_2320 | Homo sapiens (Human) | Human papillomavirus-related endocervical adenocarcinoma | Population: African American. |
PMID:4639815 PMID:5902315 PMID:20215515 |
Cancer cell line | Female | HeLa (BU-25), HeLa BU25, HeLa Bu25, HeLa/BU-25, HeLa(BU25), HeLa TK- (BU 25), Bu25 TK-, BU25 TK-, Bu25TK- | ECACC | 85022104 | CLO:CLO_0002050, CLO:CLO_0050929, CLDB:cl506, cancercelllines:CVCL_2320, Cosmic:753537, ECACC:85022104, GEO:GSM827315, Progenetix:CVCL_2320, RCB:RCB0205, Wikidata:Q54882520 |
cvcl_0058 | CVCL_2320 | 2026-07-25 04:40:44 | 0 | |
|
HeLa 229 Resource Report Resource Website 100+ mentions |
ECACC Cat# 86090201, RRID:CVCL_1276 | Homo sapiens (Human) | Human papillomavirus-related endocervical adenocarcinoma | Population: African American. |
PMID:1522048 PMID:2754009 PMID:14185313 |
Cancer cell line | Female | HeLa-229, HeLa229 | ECACC | 86090201 | BTO:BTO_0005030, CLO:CLO_0003685, CLO:CLO_0003698, CLDB:cl1604, CLDB:cl1605, CLDB:cl1606, ATCC:CCL-2.1, BCRC:60290, CCRID:1101HUM-PUMC000181, CCRID:3101HUMTCHu20, CCRID:4201HUM-CCTCC00335, CCTCC:GDC0335, ChEMBL-Cells:CHEMBL4483175, ChEMBL-Targets:CHEMBL4483246, CLS:305056, ECACC:86090201, IZSLER:BS TCL 21, JCRB:JCRB9086, KCLB:10002.1, PubChem_Cell_line:CVCL_1276, Wikidata:Q54882513 |
cvcl_0030 | CVCL_1276 | 2026-07-25 04:40:44 | 316 | |
|
HEp-2C Resource Report Resource Website Contaminated |
ECACC Cat# 85020207, RRID:CVCL_2940 | Homo sapiens (Human) | Human papillomavirus-related endocervical adenocarcinoma | Population: African American., Problematic cell line: Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative (PubMed=20143388).. | PMID:20143388 | Cancer cell line | Female | Hep-2C | ECACC | 85020207 | CLO:CLO_0003709, CLDB:cl1656, AddexBio:C0008008/5058, BioSample:SAMN03151707, ECACC:85020207, Wikidata:Q54882763 |
cvcl_1906 | CVCL_2940 | 2026-07-25 04:40:50 | 0 | |
|
HEp-2 Resource Report Resource Website 1000+ mentions Contaminated Discontinued |
ECACC Cat# 86030501, RRID:CVCL_1906 | Homo sapiens (Human) | Human papillomavirus-related endocervical adenocarcinoma | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. |
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958 |
Cancer cell line | Female | Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 | ECACC | 86030501 | BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 | CVCL_1906 | 2026-07-25 04:40:50 | 2889 | |
|
Hepa-1c1c7 Resource Report Resource Website 100+ mentions |
ECACC Cat# 95090613, RRID:CVCL_0328 | Mus musculus (Mouse) | Hepatocellular carcinoma of the mouse |
PMID:106390 PMID:4362668 PMID:6300048 PMID:7462248 PMID:18959748 PMID:31220119 |
Cancer cell line | Female | Hepa 1c1c7, Hepa1c1c7, Hepa 1-clc7 | ECACC | 95090613 | BTO:BTO_0002894, CLO:CLO_0003712, MCCL:MCC:0000224, CLDB:cl1660, CLDB:cl1661, CLDB:cl4932, ATCC:CRL-2026, BCRC:60104, BCRJ:0102, BioSample:SAMN11397638, ECACC:95090613, ICLC:ATL98016, KCLB:22026, Lonza:1224, Wikidata:Q54882812 |
cvcl_s550 | CVCL_0328 | 2026-07-25 04:40:51 | 190 |
Can't find your Cell Line?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific cell line, it's easier to enter an RRID or add the vendor information to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.
If you still could not find your cell line in the search results, please help us by registering it into the system — it's easy. Register it with the Cellosaurus. An RRID will be generated in 1-2 business days.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the Neuroscience Information Framework Project, designed to serve the biomedical research community. NIF maintains the largest searchable collection of neuroscience data, the largest catalog of biomedical resources, and the largest ontology for neuroscience on the web. We welcome all feedback and suggestions and are actively looking for resource providers to make their resources accessible through NIF. Learn about the tools available to help you share your data and discover a dynamic inventory of Web-based neuroscience resources.
